Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1892 (LINC01892)
- Target
- LINC01892
- Molecular classification
- Long intergenic non-coding RNA (lincRNA), Non-coding RNA, Long non-coding RNA (lncRNA)
01
Overview
LINC01892 (Long intergenic non-protein coding RNA 1892) is a member of the long intergenic non-coding RNA (lincRNA) family, which are autonomously transcribed RNA molecules longer than 200 nucleotides that do not overlap protein-coding genes. LincRNAs are part of the larger long non-coding RNA (lncRNA) class, and they play roles in gene expression regulation, chromatin remodeling, RNA stabilization, and potentially enhancer-associated activity. While some lincRNAs are increasingly recognized as participants in disease mechanisms, including cancer, there is currently no direct evidence that LINC01892 itself is a therapeutic target, nor are there known drugs, disease associations, or biomarkers reported for this specific molecule. LINC01892 is annotated in gene databases but has not been specifically functionally characterized to date.
- Other names
- LINC01892
02
Biological functions
Regulation of gene expressionChromatin remodelingRNA stabilizationTranscription regulationPotential enhancer-like activity
03
Disease associations
Currently, no disease association reported specifically for LINC01892, but the lincRNA class has recognized roles in various diseases, particularly cancer and gene regulation disorders
Beyond the preview
Go deeper on Long intergenic non-protein coding RNA 1892 (LINC01892).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1892 (LINC01892).